Loading...

Hygrovest Limited

HGV.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
A$0.05
A$0.00(0.00%)

Hygrovest Limited (HGV.AX) Financial Performance & Income Statement Overview

Review Hygrovest Limited (HGV.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
2988.89%
2988.89%
Operating Income Growth
30.19%
30.19%
Net Income Growth
96.71%
96.71%
Operating Cash Flow Growth
-128.34%
128.34%
Operating Margin
845.21%
845.21%
Gross Margin
100.00%
100.00%
Net Profit Margin
100.38%
100.38%
ROE
-0.69%
0.69%
ROIC
-5.07%
5.07%

Hygrovest Limited (HGV.AX) Income Statement & Financial Overview

View the income breakdown for Hygrovest Limited HGV.AX across both annual and quarterly reports.

MetricQ4 2024Q2 2024Q4 2023Q3 2023
Revenue$0.00-$130500.00-$2.23M-$2.23M
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00-$130500.00-$2.23M-$2.23M
Gross Profit Ratio$0.00$1.00$1.00$1.00
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$522000.00$581000.00$804000.00$402000.00
Operating Expenses$522000.00$581000.00$804000.00$402000.00
Total Costs & Expenses$522000.00$581000.00$804000.00$402000.00
Interest Income$131000.00$75000.00$157000.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$1.37M$374000.00$1500.00$1500.00
EBITDA$844000.00-$581000.00-$5.27M-$2.64M
EBITDA Ratio$0.00$4.45$1.18$1.18
Operating Income-$522000.00-$581000.00-$804000.00-$2.64M
Operating Income Ratio$0.00$4.45$0.36$1.18
Other Income/Expenses (Net)$1.37M-$375000.00-$2.64M$0.00
Income Before Tax$844000.00-$749000.00-$5.27M-$2.64M
Income Before Tax Ratio$0.00$5.74$2.36$1.18
Income Tax Expense$196000.00$30000.00-$674000.00$337000.00
Net Income$648000.00-$779000.00-$4.60M-$2.30M
Net Income Ratio$0.00$5.97$2.06$1.03
EPS$0.003-$0.004-$0.02-$0.01
Diluted EPS$0.003-$0.004-$0.02-$0.01
Weighted Avg Shares Outstanding$210.31M$210.31M$229.53M$228.31M
Weighted Avg Shares Outstanding (Diluted)$210.31M$210.31M$229.53M$228.98M

Over the last four quarters, Hygrovest Limited's revenue moved from -$2.23M in Q3 2023 to $0.00 in Q4 2024. Operating income in Q4 2024 was -$522000.00, with a strong operating margin of N/A. Despite fluctuations in R&D and SG&A expenses, EBITDA for Hygrovest Limited remained robust at $844000.00, reflecting operational efficiency. Net income rose to $648000.00, with an EPS of $0.003. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;